High Purity Clarithromycin Powder API CAS 81103-11-9 Anti-Inflammatory Clarithromycin Pharmaceutical Intermediate Clarithromycin

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Model NO.: D-Sung Clarithromycin
• Product Name: Clarithromycin
• Name: Clarithromycin Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 81103-11-9
• Mf: C38h69no13
• Psa: 182.91000
• Logp: 2.43970
• Melting Point: 217-220
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 10kg/Month

Product Description

High Purity Clarithromycin Powder API CAS 81103-11-9 Anti-Inflammatory Clarithromycin Pharmaceutical Intermediate Clarithromycin

Product Description

Product Details

 

Product name	clarithromycin
Appearance	White powder
Cas number	81103-11-9
MF	C38H69NO13
Shelf life	2 years

Clarithromycin, also known as methylerythromycin, is a derivative of erythromycin. It was successfully developed by Taisho Company in Japan in the early 1990s and registered under the trade name Clarith. Later, Taisho transferred its technology to Abbott Laboratories in the United States. In 1990, it was listed in Ireland and Italy, and in October 1991, it was approved by the FDA as a Class IB new drug, with the commodity name Biaxin. In 1993, it was listed in Hong Kong, China with Klacid. In Europe and Asia, the commodity name Klaxian has been listed in more than 50 countries around the world. And it plays an important role in clinical practice.

Application&Function

It is suitable for the following infections caused by clarithromycin sensitive bacteria:
1, nasopharyngeal infection: tonsillitis, pharyngitis, sinusitis.
2. Lower respiratory tract infection: acute bronchitis, acute onset of chronic bronchitis and pneumonia.
3. Skin and soft tissue infections: impetigo, erysipelas, folliculitis, furuncle and wound infection.
4. Urethritis and cervicitis caused by acute otitis media, mycoplasma pneumonia, chlamydia trachomatis, etc.
5, also used for Legionella infection, or combined with other drugs for the treatment of mycobacterium avium infection, Helicobacter pylori infection.

Specification